Moderate, refractory Atopic dermatitis

DrugDrug NameDrug Description
DB14973AbrocitinibA kinase inhibitor used to treat moderate-to-severe atopic dermatitis in adults.
DB15091UpadacitinibAn oral Janus kinase (JAK)1-selective inhibitor used in the treatment of moderate to severe rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and severe atopic dermatitis, including in patients who did not respond well to other therapies.
DrugDrug NamePhaseStatusCount